| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8814908 | European Psychiatry | 2018 | 10 Pages |
Abstract
This study suggests a specific immune-inflammatory biomarker pattern for established SCH (NFκB, PGE2, iNOS, and COX-2) that differentiates it from BD and HC. In future, their pharmacological modulation may constitute a promising therapeutic target.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
L. GarcÃa-Álvarez, J.R. Caso, M.P. GarcÃa-Portilla, L. de la Fuente-Tomás, L. González-Blanco, P. Sáiz MartÃnez, J.C. Leza, J. Bobes,